Literature DB >> 3168130

Heart rate response to atropine in humans anaesthetized with five different techniques.

H Yamaguchi1, S Dohi, S Sato, H Naito.   

Abstract

Atropine, 0.01 mg.kg-1, was given intravenously before the start of surgery to 169 patients who were anaesthetized with one of five different techniques; halothane, enflurane, cervical epidural, lumbar epidural or narcotic anaesthesia in addition to nitrous oxide and oxygen. Atropine produced a significant increase in heart rate (HR) within 1 min in all patients studied; the HR increases in patients anaesthetized with halothane (37 +/- 11 beats.min-1, n = 37) or narcotic (34 +/- 12 beats.min-1, n = 30) were significantly greater than in those anaesthetized with enflurane (25 +/- 10 beats.min-1, n = 35; P less than 0.01) or epidural anaesthesia. Because of the presence of an acute cardiac sympathectomy, the patients who received cervical epidural anaesthesia were expected to have different responses to the atropine. However, there was no significant difference in the HR increases between the patient groups with cervical (19 +/- 12 beats.min-1, n = 32) and lumbar (22 +/- 8 beats.min-1, n = 35) epidural anaesthesia. Atropine also produced a small but significant increase in arterial pressure in all five groups of patients. These results suggest that the cardiac responses to atropine may differ depending on the individual anaesthetic agent used, and are likely dependent upon the agent's effect on autonomic nervous system activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3168130     DOI: 10.1007/BF03026889

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  27 in total

Review 1.  Cardiovascular control mechanisms in the conscious state.

Authors:  S F Vatner; E Braunwald
Journal:  N Engl J Med       Date:  1975-11-06       Impact factor: 91.245

2.  Effect of atropine on the heart-rate.

Authors:  H J MORTON; E T THOMAS
Journal:  Lancet       Date:  1958-12-20       Impact factor: 79.321

3.  Effects of lidocaine on myocardial contractility and baroreflex control of heart rate in conscious dogs.

Authors:  A Edouard; A Berdeaux; J Langloys; K Samii; J F Giudicelli; Y Noviant
Journal:  Anesthesiology       Date:  1986-03       Impact factor: 7.892

4.  Bradycardia delays the onset of action of intravenous atropine in infants.

Authors:  G Zimmerman; D J Steward
Journal:  Anesthesiology       Date:  1986-09       Impact factor: 7.892

5.  Nitrous oxide: an anesthetic for experiments in cats.

Authors:  J L Venes; W F Collins; A Taub
Journal:  Am J Physiol       Date:  1971-06

6.  A comparison of the neuromuscular blocking and vagolytic effects of ORG NC45 and pancuronium.

Authors:  S L Son; B E Waud; D R Waud
Journal:  Anesthesiology       Date:  1981-07       Impact factor: 7.892

7.  Vagal component of the chronotropic response to baroreceptor stimulation in man.

Authors:  N M Greene; R G Bachand
Journal:  Am Heart J       Date:  1971-07       Impact factor: 4.749

8.  Effects of halothane, thiamylal, and ketamine on central sympathetic and vagal tone.

Authors:  T Yamamura; T Kimura; K Furukawa
Journal:  Anesth Analg       Date:  1983-02       Impact factor: 5.108

9.  [Depressant effects of inhalational anesthetic halothane on autonomic nervous activities].

Authors:  T Kimura
Journal:  Hokkaido Igaku Zasshi       Date:  1985-03

10.  Effects of intravenous administration of glycopyrrolate and atropine in anaesthetised patients.

Authors:  R K Mirakhur; C J Jones; J W Dundee
Journal:  Anaesthesia       Date:  1981-03       Impact factor: 6.955

View more
  2 in total

Review 1.  Anticholinergic drugs and anaesthesia.

Authors:  R K Mirakhur
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

2.  Atropine-induced heart rate changes: a comparison between midazolam-fentanyl-propofol-N2O and midazolam-fentanyl-thiopentone-enflurane-N2O anaesthesia.

Authors:  G Cross; D Gaylard; M Lim
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.